Ketamine and fMRI BOLD signal: Distinguishing between effects mediated by change in blood flow versus change in cognitive state
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
No human fMRI studies have examined ketamine effects on the BOLD signal change associated with cognitive task performance. We wished to distinguish between effects on 1) cerebral blood flow, with resultant change in BOLD signal; and 2) cognition and neural mechanisms underlying BOLD signal change associated with task performance. Eight right‐handed men (mean age 28.75 years) received ketamine or saline i.v. in a randomized, double‐blind manner (bolus 0.23 mg/kg; 0.5 mg/kg over 45 min to a maximum 1 hr). Subjects viewed 10 alternating 30‐sec blocks of faces with neutral expressions and a fixation cross and discriminated gender of faces. Gradient echo echoplanar images were acquired on a GE Signa 1.5 T Neurovascular system. One hundred T2‐weighted images depicting BOLD contrast were acquired over 5 min (for each task) at each of 14 near‐axial noncontiguous 7‐mm thick planes. Ketamine significantly increased dissociative phenomena and negative symptoms, but did not affect performance of the gender discrimination task. Significant BOLD signal change was demonstrated predominantly in occipitotemporal cortex with both ketamine and placebo. Only two clusters in middle occipital gyrus (BA 18) and precentral gyrus (BA 4) showed significantly decreased BOLD signal change during ketamine compared to placebo. BOLD signal change was not significantly greater in any region during ketamine. Our findings demonstrate subtle rather than major differences between the effects of ketamine and placebo upon the BOLD signal change during perception of face–non face contrast. We suggest that they represent task‐dependent effects of the drug/placebo, rather than task‐independent effects of the drug per se, and indicate that the effects of ketamine on cerebral blood flow are predominantly focal and task‐dependent, rather than global and task‐independent. Hum. Brain Mapping 18:135–145, 2003. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A specific neural substrate for perceiving facial expressions of disgust
Phillips, M. L., Young, A. W., Senior, C., Brammer, M., Andrew, C., Calder, A. J., Bullmore, E. T., Perrett, D. I., Rowland, D., Williams, S. C. R., et al. (1997) · Nature · doi:10.1038/39051 · Cited by 1,609 · cited 2×
“In the scanner, subjects viewed 10 alternating 30-sec blocks of mildly (25%) happy faces, employed in previous studies as neutral expressions [e.g., Phillips et al., 1997, 1998 ], and a fixation cross, presented as a white cross on a black background.”
MethodSelf-citationBullmore, E. T., Suckling, J., Overmeyer, S., Rabe-Hesketh, S., Taylor, E., & Brammer, M. J. (1999) · IEEE Transactions on Medical Imaging · doi:10.1109/42.750253 · Cited by 1,088 · cited 3×
“After motion correction [Bullmore et al., 1999a], periodic change in T2-weighted signal intensity at the (fundamental) experimentally determined frequency of alternation between A and B conditions ( 1/60 Hz in all three experimental conditions) was estimated by an iterated least squares fit of a…”
MethodPuce, A., Allison, T., Asgari, M., Gore, J. C., & McCarthy, G. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-16-05205.1996 · Cited by 987 · cited 3×
“This is a task for which the neural correlates or changes in BOLD signal have been identified previously in several studies, and are known to involve predominantly occipitotemporal cortex [e.g., Haxby et al., 1996; Puce et al., 1996].”
BackgroundResultBremner, J. D., Krystal, J. H., Putnam, F. W., Southwick, S. M., Marmar, C., Charney, D. S., & Mazure, C. M. (1998) · Journal of Traumatic Stress · doi:10.1023/a:1024465317902 · Cited by 817 · cited 1×
“Subjects completed the Clinician Administered Dissociative States Scale (CADSS) [ Bremner et al., 1991 ], the depersonalization scale [Sierra and Berrios, 2000], and the Brief Psychiatric Rating Scale (BPRS) [Overall and Gorham, 1962] starting approximately 5 min after the bolus dose.”
MethodThe Cambridge Depersonalisation Scale: a new instrument for the measurement of depersonalisation
Sierra, M., & Berrios, G. E. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00100-1 · Cited by 467
Vollenweider, F. X., Leenders, K. L., Øye, I., Hell, D., & Angst, J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00042-9 · Cited by 413
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.805 · Cited by 392 · cited 3×
“Indeed, consistent with our findings was the demonstration in the Brier et al. [1997] study, using FDGPET and a task to control for mental activity (as in our design), of no significant difference in global metabolic activity between ketamine and placebo infusion between drug conditions.”
BackgroundInfluentialMoretti, R. J., Hassan, S. Z., Goodman, L. I., & Meltzer, H. Y. (1984) · Anesthesia & Analgesia · doi:10.1213/00000539-198412000-00007 · Cited by 51
Cited by
Krystal, J. H., D'Souza, D. C., Mathalon, D., Perry, E., Belger, A., & Hoffman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1582-z · Cited by 530
Deakin, J. F. W., Lees, J., McKie, S., Hallak, J. E. C., Williams, S. R., & Dursun, S. M. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.37 · Cited by 311
Self-citationScheidegger, M., Walter, M., Lehmann, M., Metzger, C., Grimm, S., Boeker, H., Boesiger, P., Henning, A., & Seifritz, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044799 · Cited by 282
“While pharmacological effects of ketamine on task-induced fMRI BOLD signals have been studied extensively [56–62], this is the first randomized, placebo-controlled, double-blind, crossover study demonstrating changes in resting state functional connectivity in response to ketamine administration in healthy subjects.”
BackgroundCorlett, P. R., Honey, G. D., Aitken, M. R. F., Dickinson, A., Shanks, D. R., Absalom, A. R., Lee, M., Pomarol-Clotet, E., Murray, G. K., McKenna, P. J., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.611 · Cited by 182
Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature
Ionescu, D. F., Felicione, J. M., Gosai, A., Cusin, C., Shin, P., Shapero, B. G., & Deckersbach, T. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000179 · Cited by 91
“During ketamine administration, subjects experience emotional blunting, which may be associated with reduced limbic responses to emotional stimuli.(54,55) It is possible that by decreasing the activity of deep limbic structures (thought to be involved in the pathophysiology of depression, such as the amygdala), ketami…”
Glycine transport inhibitors in the treatment of schizophrenia
Javitt, D. C. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_12 · Cited by 83
Ketamine administration reduces amygdalo‐hippocampal reactivity to emotional stimulation
Scheidegger, M., Henning, A., Walter, M., Lehmann, M., Kraehenmann, R., Boeker, H., Seifritz, E., & Grimm, S. (2016) · Human Brain Mapping · doi:10.1002/hbm.23148 · Cited by 79
“…report a reduction in amygdala and perihippocampal reactivity following different antidepressant drugs both in healthy and depressed subjects [Abel et al., 2003b; Chen et al., 2008; Delaveau et al., 2011; Fu et al., 2004; McCabe and Mishor, 2011; Sheline et al., 2001; van Marle et al., 2011;…”
BackgroundResultInfluential
Metadata
- Authors
- Abel, K. M., Allin, M. P. G., Kucharska‐Pietura, K., Andrew, C., Williams, S., David, A. S., & Phillips, M. L.
- Venue
- Human Brain Mapping
- Publisher
- Wiley
- Published
- 2002-12-31
- Volume
- 18
- Issue
- 2
- Pages
- 135-145
- ISSN
- 1065-9471 (ISSN-L)
- 1097-0193
- OpenAlex
- W2158272333
- Cited by
- 55
- References
- 8
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.